| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.009 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |